Shield Therapeutics Share Discussion Threads

[little minx] 18/6/2021 08:10

I can't read any RNS stating a delay. The end of all the RNS read the same.

[eastlands] 18/6/2021 08:08

Which bit are you referring to that sounds like a delay? Literally just a directorate change with no detail regarding US launch

[reviewwworld] 18/6/2021 08:06

Agree reads as delay omitting "June" from wording. Now with new CEO in place and other recent hires, it could be a long term positive ie he didn't like their current proposed marketing strategy and is already changing things around. However, short term it is undoubtedly a negative as any delay is.

[little minx] 18/6/2021 07:52

It's the same on all of them

[oapknob1] 18/6/2021 07:49

18/6/21 - The Group plans to launch Accrufer(R) in the US during 2021 through a highly experienced sales and marketing team.

London, UK, 21 May 2021: Shield Therapeutics plc (LSE: STX), a commercial stage pharmaceutical company with a focus on addressing iron deficiency with its lead product Feraccru(R)/Accrufer(R) (ferric maltol), provides an update on its preparations to launch Accrufer(R) in the US, confirming the Group remains on track to launch by end of June 2021.

[oapknob1] 18/6/2021 07:44

Not happy with the wording in this RNS. Sounds like a delay

[friskymickey] 17/6/2021 18:03

My pain is far greater than six days. Will continue to hold as i see great potential but do not worry there will not be any more rhetorical questions from me.

[cafc69] 17/6/2021 16:43

Lol , wish I never got involved !

[eastlands] 17/6/2021 16:17

Strange trading sessions recently

[livewireplus] 17/6/2021 14:56

That is during the six days you have been a member of advfn... ? (Rhetorical question, isn't it?)

[friskymickey] 17/6/2021 14:11

Great fun watching this go down every day :(

[friskymickey] 17/6/2021 14:11

Great fun watching this go down every day :(

[kalkaar] 17/6/2021 12:42

absolutely agree, great time to build/add to a position.. each to their own in terms of investment horizon and objectives..

been decent buys going through for days so hopefully the overhang will be done shortly

[dandu69] 17/6/2021 12:41

You can buy the shares for less than mid price so expect many "sells" to be buys. I would think it`s reasonable to expect an update RNS within the next 2 weeks.

[babbler] 17/6/2021 12:30

As long as they are gone before USA rns who cares? Build a holding. Their loss.

[kalkaar] 17/6/2021 12:28

seems placing investors still offloading as there's been ample stock available on the offer for a number of sessions now..

[little minx] 17/6/2021 11:01

Thank you. An update would be great and maybe that's the reason behind the share options the other day.

[greenknight1] 17/6/2021 10:37

Last update said - we are currently on track for the US launch by the end of June 2021.Hopefully an RNS soon to confirm this should get the price moving.

[little minx] 17/6/2021 09:58

Are we not due an update this month?

[little minx] 16/6/2021 14:18

The spread isn't helping either

[best1467] 16/6/2021 14:15

Would be very welcome if he made a purchase from is own pocket and send out the right signal.
But when your just about to be handed 1m with a further 600k virtually guaranteed it’s unlikely IMHO

[melody9999] 16/6/2021 13:01

was Madison promised 1M on appointment? I'd like to see him buy some as well.

[tradertrev] 16/6/2021 08:59

The two awards if vested in full amount to roughly 0.75% of the equity. If the CEO executes well on the US market opportunity alone the shares will be up by miles more than 50% from here and no-one will begrudge him his money.

[frrinvest] 16/6/2021 08:49

I remember Tim W (now ex CEO) bought 100,000 shares at around 69p a few months ago. I guess others bought in the placings too?